Poxel S.A. (POXEL.PA)

EUR 0.13

(-0.94%)

Total Assets Summary of Poxel S.A.

  • Poxel S.A.'s latest annual total assets in 2023 was 4.82 Million EUR , down -86.11% from previous year.
  • Poxel S.A.'s latest quarterly total assets in 2023 FY was - EUR , down -100.0% from previous quarter.
  • Poxel S.A. reported annual total assets of 34.71 Million EUR in 2022, down -36.76% from previous year.
  • Poxel S.A. reported annual total assets of 54.88 Million EUR in 2021, down -15.66% from previous year.
  • Poxel S.A. reported quarterly total assets of - EUR for 2023 FY, down -100.0% from previous quarter.
  • Poxel S.A. reported quarterly total assets of 4.82 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Poxel S.A. (2023 - 2010)

Historical Annual Total Assets of Poxel S.A. (2023 - 2010)

Year Total Assets Total Assets Growth
2023 4.82 Million EUR -86.11%
2022 34.71 Million EUR -36.76%
2021 54.88 Million EUR -15.66%
2020 65.07 Million EUR -9.99%
2019 72.3 Million EUR -31.48%
2018 105.51 Million EUR 58.07%
2017 66.75 Million EUR 32.7%
2016 50.3 Million EUR 7.38%
2015 46.84 Million EUR 238.84%
2014 13.82 Million EUR 12.72%
2013 12.26 Million EUR 49.9%
2012 8.18 Million EUR -19.58%
2011 10.17 Million EUR -19.86%
2010 12.69 Million EUR 0.0%

Peer Total Assets Comparison of Poxel S.A.

Name Total Assets Total Assets Difference
ABIONYX Pharma SA 14.71 Million EUR 67.213%
ABIVAX Société Anonyme 327.06 Million EUR 98.525%
Adocia SA 24.95 Million EUR 80.674%
Aelis Farma SA 26.28 Million EUR 81.648%
Biophytis S.A. 11.93 Million EUR 59.593%
Advicenne S.A. 12.4 Million EUR 61.127%
genOway Société anonyme 31.84 Million EUR 84.854%
IntegraGen SA 8 Million EUR 39.715%
Medesis Pharma S.A. 1.92 Million EUR -150.372%
Neovacs S.A. 47.53 Million EUR 89.853%
NFL Biosciences SA 3.97 Million EUR -21.467%
Plant Advanced Technologies SA 14.91 Million EUR 67.659%
Quantum Genomics Société Anonyme 3.74 Million EUR -28.724%
Sensorion SA 46.49 Million EUR 89.627%
Theranexus Société Anonyme 7.23 Million EUR 33.363%
TME Pharma N.V. 2.49 Million EUR -93.617%
Valbiotis SA 33.24 Million EUR 85.494%
TheraVet SA 7.53 Million EUR 35.985%
Valerio Therapeutics Société anonyme 35.27 Million EUR 86.327%
argenx SE 4.11 Billion EUR 99.883%
BioSenic S.A. 9.55 Million EUR 49.545%
Celyad Oncology SA 16.28 Million EUR 70.378%
DBV Technologies S.A. 165.65 Million USD 97.088%
Galapagos NV 4.35 Billion EUR 99.889%
Genfit S.A. 173.87 Million EUR 97.226%
GeNeuro SA 6.31 Million EUR 23.601%
Hyloris Pharmaceuticals SA 47.68 Million EUR 89.885%
Innate Pharma S.A. 184.19 Million EUR 97.382%
Inventiva S.A. 69.13 Million EUR 93.024%
MaaT Pharma SA 42.93 Million EUR 88.766%
MedinCell S.A. 36.94 Million EUR 86.947%
Nanobiotix S.A. 93.89 Million EUR 94.864%
Onward Medical N.V. 43.62 Million EUR 88.945%
Oryzon Genomics S.A. 106.9 Million EUR 95.488%
OSE Immunotherapeutics SA 81.9 Million EUR 94.111%
Oxurion NV 6.55 Million EUR 26.366%
Pharming Group N.V. 426.33 Million EUR 98.869%
GenSight Biologics S.A. 9.08 Million EUR 46.924%
Transgene SA 45.21 Million EUR 89.334%
Financière de Tubize SA 1.92 Billion EUR 99.749%
UCB SA 15.53 Billion EUR 99.969%
Valneva SE 469.39 Million EUR 98.972%
Vivoryon Therapeutics N.V. 30.82 Million EUR 84.356%